The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
RNA interference: From gene silencing to gene-specific therapeutics
Open accessAbstract
In the past 4 years, RNA interference (RNAi) has become widely used as an experimental tool to analyse the function of mammalian genes, both in vitro and in vivo. By harnessing an evolutionary conserved endogenous biological pathway, first identified in plants and lower organisms, double-stranded RNA (dsRNA) reagents are used to bind to and promote the degradation of target RNAs, resulting in knockdown of the expression of specific genes. RNAi can be induced in mammalian cells by the introduction of synthetic double-stranded small interfering RNAs (siRNAs) 21–23 base pairs (bp) in length or by plasmid and viral vector systems that express double-stranded short hairpin RNAs (shRNAs) that are subsequently processed to siRNAs by the cellular machinery. RNAi has been widely used in mammalian cells to define the functional roles of individual genes, particularly in disease. In addition, siRNA and shRNA libraries have been developed to allow the systematic analysis of genes required for disease processes such as cancer using high throughput RNAi screens. RNAi has been used for the knockdown of gene expression in experimental animals, with the development of shRNA systems that allow tissue-specific and inducible knockdown of genes promising to provide a quicker and cheaper way to generate transgenic animals than conventional approaches. Finally, because of the ability of RNAi to silence disease-associated genes in tissue culture and animal models, the development of RNAi-based reagents for clinical applications is gathering pace, as technological enhancements that improve siRNA stability and delivery in vivo, while minimising off-target and nonspecific effects, are developed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–211 of 211
Inhibiting severe acute respiratory syndrome-associated coronavirus by small interfering RNA.
张仁礼, 郭中敏, 陆家海, 孟锦绣, 周灿权, 詹希美, 黄冰, 余新炳, Huang, M., Pan, X., et al. (2003) · PubMed · Cited by 30
Brazas, R. M., & Hagstrom, J. E. (2005) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(04)92007-1 · Cited by 30
Localized permanent epidemics: the genesis of chloroquine resistance in Plasmodium falciparum.
Verdrager, J. (1995) · PubMed · Cited by 29
Xu, J., Li, L., Qian, Z., Hong, J., Shen, S., & Huang, W. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.016 · Cited by 26
Freimann, S., Ben‐Ami, I., Hirsh, L., Dantes, A., Halperin, R., & Amsterdam, A. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.027 · Cited by 24
Vernick, K. D., & Waters, A. P. (2004) · New England Journal of Medicine · doi:10.1056/nejmcibr042899 · Cited by 20
Genomic instability and cancer: scanning the Caenorhabditis elegans genome for tumor suppressors
van Haaften, G. W., Plasterk, R. H. A., & Tijsterman, M. (2004) · Oncogene · doi:10.1038/sj.onc.1208011 · Cited by 17
Systemic Delivery of Synthetic siRNAs
Sørensen, D. R., & Sioud, M. (2010) · Methods in molecular biology · doi:10.1007/978-1-60761-657-3_6 · Cited by 16
Genes for asthma: much ado about nothing?
Whittaker, P. A. (2003) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(03)00035-3 · Cited by 13
Self-citationValidation of GABAA Receptor Subtypes as Potential Drug Targets by Using Genetically Modified Mice
Rosahl, T. W. (2003) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007033482823 · Cited by 13
Yin, Z., Ren, C., Li, F., Yang, X.-Y., Li, H., Zhao, M., & Yao, K. (2004) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/36.11.749 · Cited by 8
Cited by
Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis
Cully, M., You, H., Levine, A. J., & Mak, T. W. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1819 · Cited by 1,233
Jackson, A. L., & Linsley, P. S. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3010 · Cited by 1,083
Progress towards in Vivo Use of siRNAs
Behlke, M. A. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.01.001 · Cited by 677
siRNA delivery systems for cancer treatment
Oh, Y.-K., & Park, T. G. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.04.018 · Cited by 645
Inorganic Nanoparticles as Carriers of Nucleic Acids into Cells
Sokolova, V., & Epple, M. (2008) · Angewandte Chemie International Edition · doi:10.1002/anie.200703039 · Cited by 581
Metadata
- Authors
- Leung, R. K. M., & Whittaker, P. A.
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2005-08
- Volume
- 107
- Issue
- 2
- Pages
- 222-239
- ISSN
- 0163-7258 (ISSN-L)
- OpenAlex
- W2110538950
- Cited by
- 382
- References
- 211
- FWCI
- 10.83
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.